Get started
Author

Alexandra Cantero

Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics
2022 · Mariano Provencio, Manuel Cobo, et al. · BMC Cancer · 15
Analysis of Diagnostic Delay and its Impact on Lung Cancer Survival: Results From the Spanish Thoracic Tumor Registry
2024 · Cristina Candal-Pedreira, Alberto Ruano-Ravina, et al. · Archivos de Bronconeumología · 11
Incidence of second primary cancers in lung cancer survivors by oncological treatment: a nationwide prospective cohort study in Spain
2025 · Mariano Provencio, Manuel Cobo, et al. · The Lancet Regional Health - Europe · 4
Association Between Cutaneous Immune-Related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer
2025 · José Miguel Jurado, Vanesa Gutiérrez, et al. · Journal of Clinical Medicine · 4
PDF
Prospective germline exome and machine learning-based risk score identify predictive and prognostic biomarkers of immunotherapy outcomes in advanced non-small cell lung cancer
2026 · Andrea González-Hernández, Alberto Ríos, et al. · Journal of Translational Medicine · 2
Biomarker landscape in advanced NSCLC: insights from a national prospective registry
2025 · Mariano Provencio, Manuel Cobo, et al. · Lung Cancer · 2
Oncogene-addicted solid tumors and microbiome—lung cancer as a main character: a narrative review
2024 · Mora Guardamagna, May-Lucie Meyer, et al. · Translational Lung Cancer Research · 2
Describing differences among populations of thoracic tumors patients under and over 80 years: Data analysis from the SLCG thoracic tumor registry
2024 · Mariano Provencio, Manuel Cobo, et al. · Lung Cancer · 1
39P Determination of essential biomarkers in lung cancer: A real-world data study in Spain
2022 · V. Calvo de Juan, M. Cobo Dols, et al. · Annals of Oncology · 1
Clinical utility of comprehensive circulating tumor DNA (ctDNA) testing compared to standard-of-care (SoC) tissue testing in first-line (1L) metastatic colorectal cancer (mCRC) patients (pts).
2020 · Manuel Benavides, Julia Alcaide, et al. · Journal of Clinical Oncology · 1
Germline HLA and KIR Variation and Disease Control After Immune Checkpoint Blockade in Non-Small Cell Lung Cancer: Exposure Definition Shapes the Signal
2026 · Andrea González-Hernández, Alberto Ríos, et al. · International Journal of Molecular Sciences
Analysis code, audit rules and pre-specification documents for: Germline HLA and KIR Variation and Disease Control after Immune Checkpoint Blockade in Non-Small Cell Lung Cancer: Exposure Definition Shapes the Signal
2026 · González-Hernández, Andrea, Ríos, Alberto, et al. · Zenodo (CERN European Organization for Nuclear Research)
Germline pharmacogenomic predictors of treatment-related toxicity in non-small cell lung cancer: a systematic review of the discovery-to-implementation gap
2026 · Andrea González-Hernández, Alejandro Escamilla-Sánchez, et al. · Research Square
PDF
Clinical Characteristics and Survival Outcomes in Patients With Small Cell Lung Cancer in Spain: An Analysis of the Thoracic Tumor Registry (2016–2025)
2026 · Cristina Candal-Pedreira, Alberto Ruano-Ravina, et al. · Archivos de Bronconeumología
Characteristics and clinical outcomes of a nationwide cohort of patients with small cell lung cancer following first-line treatment: Real-world evidence
2026 · Aylen Vanessa Ospina-Serrano, Manuel Cobo, et al. · Lung Cancer
Real-world data analysis of adjuvant capecitabine for triple-negative breast cancer after neoadjuvant chemotherapy
2025 · Ana Godoy-Ortíz, Gonzalo Lendínez-Sánchez, et al. · Frontiers in Oncology
PDF
Osimertinib plus repotrectinib phase I trial in TKI-resistant non-small cell lung cancer (NSCLC) with EGFR mutations.
2025 · Andrés Aguilar Hernandez, Manuel Cobo, et al. · Journal of Clinical Oncology
PDF
Germline NQO1c.559C>T as a biomarker of genetic susceptibility to immune checkpoint blockade resistance.
2024 · Jose Carlos Benitez, Javier Oliver, et al. · Journal of Clinical Oncology
PDF
P1.21-02 Genetic Susceptibility to Immune Checkpoints Blockade Resistance
2023 · P. Marin, J.L. Onieva, et al. · Journal of Thoracic Oncology
PDF
Impact of next-generation sequencing (NGS) on the diagnosis of gliomas according to the WHO-2016 and WHO-2021 classification in routine clinical practice.
2022 · Javier Diaz-Santos, Alexandra Cantero-Gonzalez, et al. · Journal of Clinical Oncology
Long-term survival in small-cell lung cancer patients: Extension of the SMALLBRAIN study.
2022 · Javier Diaz-Santos, Alexandra Cantero-Gonzalez, et al. · Journal of Clinical Oncology
Works count: 21
Citation count: 43
H-index: 4
I10-index: 2
Year
Topic
Type